Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Erythrocyte invasion and merozoite ligand gene expression in severe and mild Plasmodium falciparum malaria.

Gomez-Escobar N, Amambua-Ngwa A, Walther M, Okebe J, Ebonyi A, Conway DJ.

J Infect Dis. 2010 Feb 1;201(3):444-52. doi: 10.1086/649902.

PMID:
20050806
2.

Variation in Plasmodium falciparum erythrocyte invasion phenotypes and merozoite ligand gene expression across different populations in areas of malaria endemicity.

Bowyer PW, Stewart LB, Aspeling-Jones H, Mensah-Brown HE, Ahouidi AD, Amambua-Ngwa A, Awandare GA, Conway DJ.

Infect Immun. 2015 Jun;83(6):2575-82. doi: 10.1128/IAI.03009-14. Epub 2015 Apr 13.

3.

Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients.

Nery S, Deans AM, Mosobo M, Marsh K, Rowe JA, Conway DJ.

Mol Biochem Parasitol. 2006 Oct;149(2):208-15. Epub 2006 Jun 22.

4.

Erythrocyte invasion phenotypes of Plasmodium falciparum in The Gambia.

Baum J, Pinder M, Conway DJ.

Infect Immun. 2003 Apr;71(4):1856-63.

5.
6.

Invasion pathways and malaria severity in Kenyan Plasmodium falciparum clinical isolates.

Deans AM, Nery S, Conway DJ, Kai O, Marsh K, Rowe JA.

Infect Immun. 2007 Jun;75(6):3014-20. Epub 2007 Apr 16.

7.

Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites.

Lopaticki S, Maier AG, Thompson J, Wilson DW, Tham WH, Triglia T, Gout A, Speed TP, Beeson JG, Healer J, Cowman AF.

Infect Immun. 2011 Mar;79(3):1107-17. doi: 10.1128/IAI.01021-10. Epub 2010 Dec 13.

8.

Baculovirus-expressed Plasmodium reichenowi EBA-140 merozoite ligand is host specific.

Zerka A, Olechwier A, Rydzak J, Kaczmarek R, Jaskiewicz E.

Parasitol Int. 2016 Dec;65(6 Pt A):708-714. doi: 10.1016/j.parint.2016.07.009. Epub 2016 Jul 19.

PMID:
27443851
9.

Analysis of Erythrocyte Invasion Mechanisms of Plasmodium falciparum Clinical Isolates Across 3 Malaria-Endemic Areas in Ghana.

Mensah-Brown HE, Amoako N, Abugri J, Stewart LB, Agongo G, Dickson EK, Ofori MF, Stoute JA, Conway DJ, Awandare GA.

J Infect Dis. 2015 Oct 15;212(8):1288-97. doi: 10.1093/infdis/jiv207. Epub 2015 Apr 2.

10.
11.

Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes.

Dolan SA, Proctor JL, Alling DW, Okubo Y, Wellems TE, Miller LH.

Mol Biochem Parasitol. 1994 Mar;64(1):55-63.

PMID:
8078523
12.

Plasmodium falciparum field isolates from South America use an atypical red blood cell invasion pathway associated with invasion ligand polymorphisms.

Lopez-Perez M, Villasis E, Machado RL, PĆ³voa MM, Vinetz JM, Blair S, Gamboa D, Lustigman S.

PLoS One. 2012;7(10):e47913. doi: 10.1371/journal.pone.0047913. Epub 2012 Oct 31.

13.

Variant merozoite protein expression is associated with erythrocyte invasion phenotypes in Plasmodium falciparum isolates from Tanzania.

Bei AK, Membi CD, Rayner JC, Mubi M, Ngasala B, Sultan AA, Premji Z, Duraisingh MT.

Mol Biochem Parasitol. 2007 May;153(1):66-71. Epub 2007 Jan 16. No abstract available. Erratum in: Mol Biochem Parasitol. 2007 Aug;154(2):195.

PMID:
17303262
14.

Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru.

Villasis E, Lopez-Perez M, Torres K, Gamboa D, Neyra V, Bendezu J, Tricoche N, Lobo C, Vinetz JM, Lustigman S.

Malar J. 2012 Oct 30;11:361. doi: 10.1186/1475-2875-11-361.

15.

Binding of aldolase and glyceraldehyde-3-phosphate dehydrogenase to the cytoplasmic tails of Plasmodium falciparum merozoite duffy binding-like and reticulocyte homology ligands.

Pal-Bhowmick I, Andersen J, Srinivasan P, Narum DL, Bosch J, Miller LH.

MBio. 2012 Sep 18;3(5). pii: e00292-12. doi: 10.1128/mBio.00292-12. Print 2012.

16.

Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity.

Persson KE, Fowkes FJ, McCallum FJ, Gicheru N, Reiling L, Richards JS, Wilson DW, Lopaticki S, Cowman AF, Marsh K, Beeson JG.

J Immunol. 2013 Jul 15;191(2):785-94. doi: 10.4049/jimmunol.1300444. Epub 2013 Jun 17.

17.

Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine.

Jiang L, Gaur D, Mu J, Zhou H, Long CA, Miller LH.

Proc Natl Acad Sci U S A. 2011 May 3;108(18):7553-8. doi: 10.1073/pnas.1104050108. Epub 2011 Apr 18.

18.

Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways.

Duraisingh MT, Maier AG, Triglia T, Cowman AF.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4796-801. Epub 2003 Apr 2.

19.

Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion.

Reed MB, Caruana SR, Batchelor AH, Thompson JK, Crabb BS, Cowman AF.

Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7509-14.

20.

A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes.

Gilberger TW, Thompson JK, Triglia T, Good RT, Duraisingh MT, Cowman AF.

J Biol Chem. 2003 Apr 18;278(16):14480-6. Epub 2003 Jan 29.

Supplemental Content

Support Center